Date | Title | Description | |
---|---|---|---|
13 May 2021 | Announcement of general shareholders’ meeting | Rovi releases the information related to its 2021 General Shareholders Meeting | Download |
13 May 2021 | On business and financial situation | The company releases the press release related to first quarter 2021 financial results | Download |
06 Apr 2021 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the first quarter of 2021 | Download |
24 Feb 2021 | On business and financial situation | The company releases the press release related to 2020 financial results | Download |
24 Feb 2021 | On business and financial situation | ROVI releases the 2020 Results presentation | Download |
Pages
Date | Title | Description | |
---|---|---|---|
06 Apr 2017 | Contratos de liquidez y contrapartida | Liquidity contract: transactions conducted in the first quarter of 2017 | Download |
13 Mar 2017 | Otros sobre negocio y situación financiera | The Company releases the presentation related to its biosimilar of Enoxaparin | Download |
07 Mar 2017 | Otros sobre negocio y situación financiera | ROVI informs that the Decentralised procedure used for the registration of its biosimilar of enoxaparin has been completed with positive outcome | Download |
16 Feb 2017 | Otros sobre Gobierno Corporativo | The Company informs about the agreements adopted by the Board of Directors | Download |
16 Feb 2017 | Informe anual de remuneraciones de los consejeros | ROVI releases the 2016 annual report regarding remuneration of the members of the Board of Directors | Download |